Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-04-15

Clinical Trial Update: LSD to Improve Cluster Headache Impact Trial [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating LSD for improving the impact of chronic cluster headache; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LSD (lysergic acid diethylamide)

Snippet

Sponsor: Radboud University Medical Center | Conditions: Chronic Cluster Headache | Phase 2 | Status: RECRUITING